SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-07-246526
Filing Date
2007-11-14
Accepted
2007-11-14 09:39:12
Documents
3
Period of Report
2007-11-08
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 11407
2 PRESS RELEASE DATED NOVEMBER 8, 2007 dex991.htm EX-99.1 7448
3 PRESS RELEASE DATED NOVEMBER 12, 2007 dex992.htm EX-99.2 10987
  Complete submission text file 0001193125-07-246526.txt   31418
Mailing Address 13950 BALLANTYNE CORPORATE PLACE UNIT 325 CHARLOTTE NC 28277
Business Address 13950 BALLANTYNE CORPORATE PLACE UNIT 325 CHARLOTTE NC 28277 704-341-1516
Chelsea Therapeutics International, Ltd. (Filer) CIK: 0001333763 (see all company filings)

IRS No.: 203174202 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51462 | Film No.: 071241091
SIC: 2836 Biological Products, (No Diagnostic Substances)